Clinical Trial

Medical Management With Endovascular Thrombectomy Versus Medical Management Alone in Patients Presenting Beyond 24 Hours of Last Known Well

Study acronym: SELECT LATE
Recruiting
View on ClinicalTrials.gov →
Summary
SELECT LATE trial aims to evaluate if addition of endovascular thrombectomy to medical management in patients presenting with acute ischemic stroke and a proximal large vessel occlusion in the anterior circulation between 24 and 72 hours of stroke onset results in achieving better functional outcomes (measured using modified Rankin Scale Scores) at 90-day follow-up (± 15 days).
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2025-08-04; most recent amendment 2026-07-01.
Status change: Not Yet Recruiting → Recruiting 2026-04-02
Trial Details
NCT Number NCT07115940
Lead Sponsor Amrou Sarraj
Collaborators: Patient-Centered Outcomes Research Institute
Conditions Acute Ischemic Stroke
Enrollment 408 participants
Start Date 2026-04-13
Primary Completion 2029-11-01 (estimated)
Study Completion 2029-12-01 (estimated)
Updated on ClinicalTrials.gov 2026-07-06